Author:
Arjmand Babak,Kokabi-Hamidpour Shayesteh,Aghayan Hamid Reza,Alavi-Moghadam Sepideh,Arjmand Rasta,Rezaei-Tavirani Mostafa,Goodarzi Parisa,Nasli-Esfahani Ensieh,Nikandish Mohsen
Reference34 articles.
1. Magrinelli F, Picelli A, Tocco P et al (2016) Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation. Parkinson’s Dis 2016:1
2. DeMaagd G, Philip A (2015) Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P & T 40(8):504–532
3. Larijani B, Goodarzi P, Payab M et al (2019) The design and application of an appropriate Parkinson’s disease animal model in regenerative medicine. Cell Biol Transl Med 13:89–105
4. DeMaagd G, Philip A (2015) Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharm Ther 40(8):504
5. Naoi M, Maruyama W (1999) Cell death of dopamine neurons in aging and Parkinson’s disease. Mech Ageing Dev 111(2–3):175–188
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In Vitro Models of Amyotrophic Lateral Sclerosis;Cellular and Molecular Neurobiology;2023-10-23